| Mary Cristina Smith, MD | |
|
62 W 7th Ave Ste 110, Spokane, WA 99204-2321 | |
| (509) 456-0262 | |
| (509) 462-5059 |
| Full Name | Mary Cristina Smith |
|---|---|
| Gender | Female |
| Speciality | Thoracic Surgery |
| Experience | 26 Years |
| Location | 62 W 7th Ave Ste 110, Spokane, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003988312 | NPI | - | NPPES |
| 2027727 | Medicaid | WA | |
| 938178 | Medicaid | AZ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | MD60353787 (Washington) | Secondary |
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | MD60353787 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Prov Sacred Hrt Med Ctr & Childs Hosp. | Spokane, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services-wa | 7911069703 | 17 |
News Archive
GE Healthcare Ltd. and ImaginAb, Inc. have executed a master research agreement around the development of new PET (Positron Emission Tomography) diagnostic imaging agents based on ImaginAb's antibody fragment technology. The agreement is launched with an initial exclusive collaboration around a novel cardiovascular target.
Seaside Therapeutics, Inc. announced today positive data from an open-label Phase 2 study of STX209 conducted in patients with autism spectrum disorders (ASD). The primary endpoint of the study, an improvement on the Irritability subscale of the Aberrant Behavior Checklist (ABC-I), achieved statistical significance (p<0.001).
In eastern Tennessee, doctors have seen firsthand how a hard-line immigration policy can affect the health and well-being of a community.
Diseased hearts may be thrown out of rhythm by structural differences - now visible for the first time - in protein groups that connect heart muscle cells, according to the authors of a study to be published in the journal Nature Communications online Jan. 20.
› Verified 3 days ago
| Entity Name | Peacehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356309553 PECOS PAC ID: 9537073960 Enrollment ID: O20031118001062 |
News Archive
GE Healthcare Ltd. and ImaginAb, Inc. have executed a master research agreement around the development of new PET (Positron Emission Tomography) diagnostic imaging agents based on ImaginAb's antibody fragment technology. The agreement is launched with an initial exclusive collaboration around a novel cardiovascular target.
Seaside Therapeutics, Inc. announced today positive data from an open-label Phase 2 study of STX209 conducted in patients with autism spectrum disorders (ASD). The primary endpoint of the study, an improvement on the Irritability subscale of the Aberrant Behavior Checklist (ABC-I), achieved statistical significance (p<0.001).
In eastern Tennessee, doctors have seen firsthand how a hard-line immigration policy can affect the health and well-being of a community.
Diseased hearts may be thrown out of rhythm by structural differences - now visible for the first time - in protein groups that connect heart muscle cells, according to the authors of a study to be published in the journal Nature Communications online Jan. 20.
› Verified 3 days ago
| Entity Name | Providence Health & Services-wa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538311287 PECOS PAC ID: 7911069703 Enrollment ID: O20090105000365 |
News Archive
GE Healthcare Ltd. and ImaginAb, Inc. have executed a master research agreement around the development of new PET (Positron Emission Tomography) diagnostic imaging agents based on ImaginAb's antibody fragment technology. The agreement is launched with an initial exclusive collaboration around a novel cardiovascular target.
Seaside Therapeutics, Inc. announced today positive data from an open-label Phase 2 study of STX209 conducted in patients with autism spectrum disorders (ASD). The primary endpoint of the study, an improvement on the Irritability subscale of the Aberrant Behavior Checklist (ABC-I), achieved statistical significance (p<0.001).
In eastern Tennessee, doctors have seen firsthand how a hard-line immigration policy can affect the health and well-being of a community.
Diseased hearts may be thrown out of rhythm by structural differences - now visible for the first time - in protein groups that connect heart muscle cells, according to the authors of a study to be published in the journal Nature Communications online Jan. 20.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mary Cristina Smith, MD 62 W 7th Ave Ste 110, Spokane, WA 99204-2321 Ph: (509) 456-0262 | Mary Cristina Smith, MD 62 W 7th Ave Ste 110, Spokane, WA 99204-2321 Ph: (509) 456-0262 |
News Archive
GE Healthcare Ltd. and ImaginAb, Inc. have executed a master research agreement around the development of new PET (Positron Emission Tomography) diagnostic imaging agents based on ImaginAb's antibody fragment technology. The agreement is launched with an initial exclusive collaboration around a novel cardiovascular target.
Seaside Therapeutics, Inc. announced today positive data from an open-label Phase 2 study of STX209 conducted in patients with autism spectrum disorders (ASD). The primary endpoint of the study, an improvement on the Irritability subscale of the Aberrant Behavior Checklist (ABC-I), achieved statistical significance (p<0.001).
In eastern Tennessee, doctors have seen firsthand how a hard-line immigration policy can affect the health and well-being of a community.
Diseased hearts may be thrown out of rhythm by structural differences - now visible for the first time - in protein groups that connect heart muscle cells, according to the authors of a study to be published in the journal Nature Communications online Jan. 20.
› Verified 3 days ago
Dr. Steven J. Nisco, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 62 W 7th Ave Ste 110, Spokane, WA 99204 Phone: 509-456-0262 Fax: 509-462-5059 | |
Dr. Donald Vernon Holbert, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Not Enrolled in Medicare Practice Location: 122 W 7th Ave, Ste 110, Spokane, WA 99204 Phone: 509-456-0262 Fax: 509-462-5059 | |
Matthew Donavon Forrester, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 62 W 7th Ave Ste 110, Spokane, WA 99204 Phone: 509-456-0262 Fax: 509-462-5059 | |
Dr. Branden R. Reynolds, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 62 W 7th Ave Ste 110, Spokane, WA 99204 Phone: 509-456-0262 Fax: 509-462-5059 | |
Kai A Ihnken, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 122 W 7th Ave Ste 110, Spokane, WA 99204 Phone: 509-462-6485 Fax: 509-462-5059 | |
Dr. Neil K. Worrall, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 62 W 7th Ave Ste 110, Spokane, WA 99204 Phone: 509-456-0262 Fax: 509-462-5059 | |
Justin Reeves, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 62 W 7th Ave Ste 110, Spokane, WA 99204 Phone: 509-456-0262 |